How Bioscience and DNA targeted medicine development is changing the pharmaceutical industry - Webinar

How Bioscience and DNA targeted medicine development is changing the pharmaceutical industry - Webinar
GSKs strategy has a strong focus on growing an understanding of the role the immune system plays in human disease as well as leveraging the increasingly large amount of human genetic and gnomic information to identify novel targets and powerful medicine.

“Science x Technology x culture = Next generation of medicines for patients” is GSKs new approach to R&D as introduced by the newly appointed Chief Scientific Officer and President of R&D, Hal
Barron. Hal has joined GSK from the google backed biotech company Calico. The new strategy has a strong focus on growing an understanding of the role the immune system plays in human disease as well as leveraging the increasingly large amount of human genetic and gnomic information to identify novel targets and powerful medicines. As part of this GSK has teamed up with “23 and me” to leverage genetic insight for the development of these new novel medicines.

The talk will include an oversight of the following:

● A new approach to medicines development focusing on immunology and genomic information

● What the impact of this new approach to medicines development has on drug delivery

● New technologies in medical device development

● Considering the patient perspective in the future of at home treatment

Registration procedure for the webinar:
Once you have registered you will receive a confirmation e-mail. At the bottom of this mail you will find a link to the webinar. You log in through this link and are forwarded to the site where the webinar is shown.
Type your e-mail address in the empty field and press ‘Enter’. You are now registered on the site and will receive a link in your inbox which transfers you straight to the recording.

Download presentations:
Click File bottom left corner of the screen when you have started the webinar, here you can download the presentation files for review.

Organiser: IDA Bioscience - The Danish Society of Engineers, IDA.

Important information regarding personal data on participant lists
Your name, title and company will appear on the attendance list for this event. The participant list is available to the organizer and the other participants on the event itself, in the form of a physical participant list and online attendance list. In addition, at some events, name tags are provided, where your name, title and company appear. If you unsubscribe from the event, your information will not appear in the attendance list.

Information
  • When

    15. nov. 2018 13:15 - 13:40
  • Where

    Webinar foran din egen pc, tablet, smartphone

  • Registration Deadline

    15. nov. 2018 - 13:15

  • Organizer

    IDA Bioscience

  • Available Seats

    266

  • Event Number

    329553